Antimicrobials: an endangered species?

International Journal of Antimicrobial Agents

Volumn 30, Issue 5, 2007, Pages 383-384

  Gould, I M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINOPENICILLANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; FLUCLOXACILLIN; METICILLIN; NAFCILLIN; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE; TIGECYCLINE;

ANTIBIOTIC THERAPY; COCHRANE LIBRARY; EDITORIAL; HISTORY; HUMAN IMMUNODEFICIENCY VIRUS; MULTIDRUG RESISTANCE; PRESCRIPTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; WORLD HEALTH ORGANIZATION;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; GUIDELINE ADHERENCE; HEALTH POLICY; HUMANS;

EID: 34848903901     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.008     Document Type: Editorial

References (25)

1. Rolinson G.N., and Geddes A.M. The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA). Int J Antimicrob Agents 29 (2007) 3-8 [Erratum. Int J Antimicrob Agents 2007;29:613.]
2. Falagas M.E., Siempos I.I., Papagelopoulos P.J., and Vardakas K.Z. Linezolid for the treatment of adults with bone and joint infections. Int J Antimicrob Agents 29 (2007) 233-239
3. Garazzino S., De Rosa F.G., Bargiacchi O., Audagnotto S., Maiello A., and Di Perri G. Haematological safety of long-term therapy with linezolid. Int J Antimicrob Agents 29 (2007) 471-483
4. Brauers J., Kresken M., Menke A., Orland A., Weiher H., and Morrissey I. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations. Int J Antimicrob Agents 29 (2007) 322-325
5. Falagas M.E., Bliziotis I.A., and Tam V.H. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 29 (2007) 9-25
6. DiPersio J.R., and Dowzicky M.J. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial. Int J Antimicrob Agents 29 (2007) 518
7. Woodford N., Dallow J.W.T., Hill R.L.R., et al. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int J Antimicrob Agents 29 (2007) 456-459
8. Daikos G.L., Karabinis A., Syriopoulou V.P., et al. VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases. Int J Antimicrob Agents 29 (2007) 471-483
9. Cornaglia G., Akova M., Amicosante G., et al. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents 29 (2007) 380-388
10. Falagas M.E., and Bliziotis I.A. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?. Int J Antimicrob Agents 29 (2007) 630-636
11. Poirel L., Nordmann P., De Champs C., and Eloy C. Nosocomial spread of QnrA-mediated quinolone resistance in Enterobacter sakazakii. Int J Antimicrob Agents 29 (2007) 223-232
12. Lee A., Yong D., Seon Choi Y., et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Int J Antimicrob Agents 29 (2007) 201-206
13. Papaparaskevas J., Pantazatou A., Stefanou I., Mela V., Galatidis N., and Avlamis A. Differences in the evolution of imipenem susceptibility among Klebsiella pneumoniae and Escherichia coli isolates during a 6-year period in a tertiary care hospital. Int J Antimicrob Agents 29 (2007) 197-200
14. MacKenzie F.M., Monnet G.L., Gould I.M., and ARPAC Steering Group. Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 58 (2007) 657-660
15. Seaton R.A., Nathwani D., Burton P., et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow antimicrobial audit tool (GAAT). Int J Antimicrob Agents 29 (2007) 693-699
16. Cooke F.J., and Holmes A.H. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents 30 (2007) 25-29
17. Davey P., Brown E., Fenelon L., et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 4 (2005) CD003543
18. Arnold S.R., and Straus S.E. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 4 (2005) CD003539
19. Petrikkos G., Markogiannakis A., Papapareskevas J., et al. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital. Int J Antimicrob Agents 29 (2007) 34-38
20. Leibovici L, Paul M, Nielsen AD, Tacconelli E, Andreassen S. The TREAT project: decision support and prediction using causal probabilistic networks. Int J Antimicrob Agents: Bloodstream Infect Suppl (in press).
21. Lode H., Torres A., and Cockle A. What drives our choices? Evidence, guidelines or habit?. Int J Antimicrob Agents 29 Suppl. 1 (2007) S17-S22
22. Roberts J.A., Paratz J., Paratz E., Krueger W.A., and Lipman J. Continuous infusion of β-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30 (2007) 11-18
23. Gould I.M., Mackenzie F.M., Maclennan G., Pacitti D., Watson E.J., and Noble D.W. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents 29 (2007) 536-543
24. Lehtinen J., and Lilius E. Promethazine renders Escherichia coli susceptible to penicillin G: real-time measurement of bacterial susceptibility by fluoro-luminometry. Int J Antimicrob Agents 30 (2007) 44-51
25. Müller B, Schuetz P, Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents: Bloodstream Infect Suppl (in press).